University of Thessaly (UTH)
Συχνότητα και σημασία της λανθάνουσας ιαιμίας από τον ιό της ηπατίτιδας Β σε ασθενείς με χρόνια ηπατίτιδα C
Abstract
dc:descriptionHepatitis B virus (HBV) and hepatitis C virus (HCV) infections are considered to be the most common causes of liver disease worldwide. Both viruses are transmitted, mainly, parenterally and they share similar risk factors for transmission. As a consequence the combined HBV and HCV infection is quite frequent, especially in HBV-endemic areas. Overt HBV and HCV coinfection has been reported to be associated with a more severe liver disease, increased frequency of hepatocellular carcinoma and resistance to ainterferon (a-IFN) therapy. Occult HBV infection is characterised by undetectable serum HBsAg but detectable HBV-DNA in serum or liver. So far, data on the prevalence and clinical significance of occult HBV infection in patients with chronic hepatitis C are missing in our country. In addition, the clinical impact of occult HBV on HCV-related disease remains controversial. The aims of the present study were: • To determine the prevalence of occult HBV infection in a large sample of consecutive patients with chronic HCV infection from CentralGreece. • To explore the possible clinical impact of occult HBV infection on HCVrelated disease. For this reason the presence or absence of HBV-DNA was associated with epidemiological, clinical, laboratory, virologic, histologic data and HBV serologic markers as well as with the response to antiviral therapy. As control groups we investigated 100 patients with diverse non-viral chronicliver diseases (disease control group) and 282 blood donors (healthy control group). The detection of HBV-DNA was significantly more frequent in patients with HCV infection compared with the disease control group, as well as with the healthy control group. In agreement with other reports we found low levels of HBV viremia in patients with HCV and occult HBV infection indicating apossible inhibitory effect of HCV on HBV as it has been reported for overt HBV and HCV co-infection. HBV-DNA seropositivity was associated neither with age, sex, the source and the duration of HCV infection nor with certain epidemiological and demographic factors (operations, conduction of tattoos, traditional practices, etc.). In addition, the detection of HBV-DNA both in HCV-infected patients and in the disease control group was not associated with several clinical (such as symptoms, disease stage, associated diseases) and laboratory parameters studied. Likewise, HBV-DNA seropositivity was not associated with virological parameters (HCV-RNA levels, HCV-genotype) in HCV patients. Occult HBV infection was not found to be associated with each of the serologic markers of HBV infection both in HCV-infected patients and the disease control group. In the 107 HCV-infected patients who had undergone liver biopsy, HBV-DNA positivity was not associated with liver histology. Finally, HBV-DNA seropositivity was not associated with the response to therapy (biochemical, virologic or histologic) either at the end of treatment or 6 months after completion of therapy In conclusion, we showed that a significant proportion of Greek patients with hepatitis C have occult HBV infection. The frequency of detectable HBVDNA was significantly increased in patients with chronic HCV-related liver disease compared to those with non-HCV-related liver diseases and healthy controls. HBV replication in HCV cases with concurrent occult HBV infection israther inhibited by the HCV, since low levels of HBV-DNA were detected. However, a spontaneous conversion/virus clearance cannot be excluded. From the clinical point of view, we demonstrated that no serologic marker of HBV infection should be used as a surrogate indicator of occult HBV infection in HCV-infected patients and in patients with non-viral hepatic diseases. Occult HBV infection does not seem to affect the clinical features and the histologic progression of liver disease in both Greek patients’ groups. However, additional studies of long-term clinical and laboratory follow-up with repeatedly PCR investigations are rather needed in order to better clarify andunderstand the pathobiological basis and significance of occult hepatitis B.
Degree
thesis:*- Grantor dc:publisher
- University of Thessaly (UTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgiadou, Sarah
- Γεωργιάδου, Σάρα
Subjects
dc:subject × 7Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/33895